By down regulating the expression of VEGF, it can inhibit the angiogenesis of breast cancer with high expression of HER-2/neu gene. The inhibition of angiogenesis is related to the inhibition of the signal transduction pathway of tylosin kinase membrane receptor tyrosine protein kinase (TPK). Here, ERBB2 is linked to breast carcinoma.